Pathophysiology of Parkinson's Disease

Displaying 51 - 53 of 53CSV
Cook, L., Schulze, J., Verbrugge, J., Beck, J. C., Marder, K. S., Saunders-Pullman, R., Klein, C., Naito, A., Alcalay, R. N., Brice, A., Kumeh, A., West, A. B., Singleton, A., Naito, A., Schüle, B., Fiske, B., Gabbert, C., Klein, C., Marras, C., … Bonifati, V. (2021). The commercial genetic testing landscape for Parkinson’s disease. Parkinsonism & Related Disorders, 92, 107–111. https://doi.org/10.1016/j.parkreldis.2021.10.001
Publication Date
Xie, T., Yuen, C. A., Kang, W., Padmanaban, M., Hain, T. C., & Nichols, J. (2021). Severity of Downgaze Palsy in the Context of Disease Duration Could Estimate Survival Duration in Patients With Progressive Supranuclear Palsy. Frontiers in Neurology, 12. https://doi.org/10.3389/fneur.2021.736784
Publication Date
Kim, S. H., Farrell, K., Cosentino, S., Vonsattel, J.-P. G., Faust, P. L., Cortes, E. P., Bennet, D. A., Louis, E. D., & Crary, J. F. (2021). Tau Isoform Profile in Essential Tremor Diverges From Other Tauopathies. Journal of Neuropathology & Experimental Neurology, 80(9), 835–843. https://doi.org/10.1093/jnen/nlab073
Publication Date